Skip to main content

Peer Review reports

From: Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for advanced or recurrent colorectal cancer (CR0802)

Original Submission
27 Dec 2013 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
6 Mar 2015 Editorially accepted
25 Mar 2015 Article published 10.1186/s12885-015-1175-3

You can find further information about peer review here.

Back to article page